Image

Provider-Focused Intervention for Maximizing HPV Vaccine Uptake in Young Cancer Survivors

Helping providers increase HPV vaccine rates in young cancer survivors.

Recruiting
9 years and older
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

Study Focus: This study aims to improve the uptake of the HPV vaccine (which helps prevent cancers caused by the human papillomavirus) in young cancer survivors aged 9-17 who are at higher risk for new cancers. The study evaluates an intervention called HPV-PROTECT used by healthcare providers in pediatric oncology clinics.

HPV-PROTECT Intervention: The intervention has three parts: 1) Provider Communication Training to better recommend the vaccine, 2) Assessment and Peer Feedback/Coaching to improve communication skills, and 3) a Provider Toolkit to help providers with vaccine-related information. It aims to increase healthcare providers' knowledge and skills in recommending the HPV vaccine and decrease barriers to vaccine uptake.

  • Duration & Visits: Participation includes completing surveys and/or interviews.
  • Eligibility: Targets healthcare providers who treat cancer survivors, and young cancer survivors aged 9-17.
  • Compensation: Not specified, but participants contribute to valuable research for improving health outcomes.

This study will offer insights into increasing HPV vaccine rates, potentially leading to broader use in clinics.

Print
Study details
    Papillomavirus Vaccines

NCT04469569

University of Alabama at Birmingham

13 December 2024

Contact a study center
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.